Concepedia

Hyun Ok

HO

Statistics

Publications

13

Citations

1K

H-Index

11

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Columbia University

Hyun Ok is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

MedicinePharmacologyMolecular PharmacologyBiochemistryDrug DiscoveryPharmacotherapyNatural SciencesChemical BiologyMedicinal ChemistryAlpha-adrenergic Pharmacology

Publications per year

1988–2012

13

Publications

13

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

Diabetes Management, Pharmacological Study, Biochemistry +15

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Linda Brockunier, Emma R. Parmee, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 199 citations · Full text

Molecular Pharmacology, Medicine, Pharmacological Agent +5

Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors

Jinyou Xu, Hyun Ok, Edward J. Gonzalez et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 76 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +7

Bovine rhodopsin with 11-cis-locked retinal chromophore neither activates rhodopsin kinase nor undergoes conformational change upon irradiation

Todd C. Zankel, Hyun Ok, Randy L. Johnson et al. · Journal of the American Chemical Society · 1990 · 48 citations

Ocular Disease, Altmetric Attention Score, Molecular Biology +20

Benzazepinone Nav1.7 blockers: Potential treatments for neuropathic pain

Scott B. Hoyt, Clare London, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 46 citations · Full text

Molecular Pharmacology, Pain Therapy, Health Sciences +9

1–5 of 13